Search - tctmd.com

Displaying 21 - 40 of 112

Sort: Relevancy | Date

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

Presentation TCT 2023

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

Presenter: Myeong-Ki Hong

October 25, 2023

Presentation TCT 2023

Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-analysis of the TWILIGHT and TICO Randomized Trials

Presenter: Usman Baber

October 23, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Yael L. Maxwell

September 05, 2023

News Conference News SCAI 2023

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

L.A. McKeown

May 22, 2023

News Daily News

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Shelley Wood

April 14, 2023

News Conference News ACC 2023

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

Yael L. Maxwell

March 09, 2023

News Daily News

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

Yael L. Maxwell

February 06, 2023

News Daily News

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Todd Neale

November 21, 2022

News Daily News

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

Yael L. Maxwell

November 03, 2022

Presentation TCT 2022

TCT 13: Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI

Presenter: Alessandro Spirito

September 17, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Shelley Wood

December 22, 2021

News Conference News TCT 2021

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

Caitlin E. Cox

November 06, 2021

Podcast TCTMD Talking Points

The TICO-STEMI Trial

October 06, 2021

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

News Conference News ACC 2021

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Yael L. Maxwell

May 15, 2021

Advertisement

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Less Than 1-Month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy After Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: A Randomized Trial

Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-analysis of the TWILIGHT and TICO Randomized Trials

What’s Going to Be Hot at TCT 2023

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Repeat Revascularization Not Increased With Solo Ticagrelor: TWILIGHT Analysis

A Bivalirudin Rebuttal: ‘Some Issues’ to Discuss With BRIGHT-4

Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA

P2Y12 Monotherapy Better Than Continued DAPT Even After Complex PCI

P2Y12 Inhibitors Top Aspirin Following Post-PCI DAPT: Network Meta-analysis

Renal Function Affects Ticagrelor/Aspirin Impact on Recurrent Stroke: CHANCE-2

TCT 13: Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

March 2022 News Roundup

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

Magnetic Endoscopy Capsule Reveals GI Damage Surprises From Antiplatelets

The TICO-STEMI Trial

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Ticagrelor Monotherapy’s Benefits Extend to Women in TWILIGHT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content